BioCardia Inc (BCDA)
2.29
+0.16
(+7.26%)
USD |
NASDAQ |
Nov 22, 14:47
BioCardia Total Assets (Quarterly): 6.267M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.267M |
June 30, 2024 | 2.89M |
March 31, 2024 | 2.679M |
December 31, 2023 | 2.987M |
September 30, 2023 | 3.747M |
June 30, 2023 | 6.389M |
March 31, 2023 | 7.128M |
December 31, 2022 | 9.793M |
September 30, 2022 | 9.179M |
June 30, 2022 | 11.27M |
March 31, 2022 | 12.84M |
December 31, 2021 | 15.72M |
September 30, 2021 | 17.33M |
June 30, 2021 | 20.22M |
March 31, 2021 | 23.31M |
December 31, 2020 | 23.42M |
September 30, 2020 | 9.502M |
June 30, 2020 | 13.13M |
March 31, 2020 | 4.384M |
December 31, 2019 | 7.678M |
September 30, 2019 | 10.68M |
June 30, 2019 | 2.716M |
March 31, 2019 | 5.157M |
December 31, 2018 | 6.417M |
September 30, 2018 | 5.556M |
Date | Value |
---|---|
June 30, 2018 | 7.661M |
March 31, 2018 | 10.41M |
December 31, 2017 | 13.54M |
September 30, 2017 | 15.86M |
June 30, 2017 | 17.76M |
March 31, 2017 | 19.78M |
December 31, 2016 | 22.08M |
September 30, 2016 | 19.48M |
June 30, 2016 | 14.02M |
March 31, 2016 | 13.95M |
December 31, 2015 | 13.88M |
September 30, 2015 | 13.78M |
June 30, 2015 | 13.70M |
March 31, 2015 | 13.62M |
December 31, 2014 | 13.54M |
September 30, 2014 | 13.49M |
June 30, 2014 | 13.44M |
March 31, 2014 | 13.38M |
December 31, 2013 | 13.33M |
September 30, 2013 | 13.31M |
June 30, 2013 | 13.28M |
March 31, 2013 | 13.28M |
December 31, 2012 | 13.30M |
September 30, 2012 | 13.39M |
June 30, 2012 | 12.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.679M
Minimum
Mar 2024
23.42M
Maximum
Dec 2020
10.49M
Average
9.340M
Median
Total Assets (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 4.205B |
The Cooper Companies Inc | 12.11B |
Theriva Biologics Inc | 40.11M |
Zevra Therapeutics Inc | 191.55M |
Instil Bio Inc | 272.56M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.514M |
Shareholders Equity (Quarterly) | 2.753M |